Please assess the completion status of the following clinical trial:

Trial Title: Cigarette Pack Inserts for Smoking Cessation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* 18 or older~* Have smoked at least 100 cigarettes in their lifetime~* Smoked at least 10 cigarettes a day in the prior month.~Exclusion Criteria:~* Use of other nicotine products besides cigarettes in the prior month.~* Pregnant women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Standard cigarette packs (control) (Type: NO_INTERVENTION): Participants will be provided with a 2 week supply of their preferred brand of cigarettes, with the only alteration being the small health warning message on the side of the pack, whose textual content will be the same as that used for the pictorial warning label conditions.
- Cigarette packs with inserts only (Type: EXPERIMENTAL): Participants will be provided with a 2 week supply of their preferred brand of cigarettes, with packs altered to include inserts with four different rotating messages to promote response efficacy beliefs (2 inserts on the benefits of cessation) or self-efficacy to quit (2 inserts with cessation tips).
- Cigarette packs with pictorial warnings only (Type: EXPERIMENTAL): Participants will be provided with a 2 week supply of their preferred brand of cigarettes, with packs altered to include four different rotating pictorial warnings showing the consequences of smoking and that cover 50% of the front and back of the pack.
- Cigarette packs with inserts and pictorial warnings (Type: EXPERIMENTAL): Participants will be provided with a 2 week supply of their preferred brand of cigarettes, with packs altered to include inserts with four rotating efficacy messages (see description above) and four rotating pictorial warnings (see above).

Based on this trial design, predict the completion outcome and termination type (if applicable).